Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 04, 2022 08:00 ET | Source: GBT Technologies Inc.

GBT’s AI based, Motion Detection Wireless Patent has been Granted

The Patent was Granted on April 12, 2022; Patent # 11,302,032 SAN DIEGO, May 04, 2022 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC PINK: GTCH) ("GBT” or the “Company”), intelligent wireless...
April 28, 2022 09:05 ET | Source: Clarus Therapeutics Holdings, Inc.

Clarus Therapeutics Announces Notice of Allowance for Patent Claims Covering JATENZO® (testosterone undecanoate)

JATENZO is the first FDA-approved oral softgel for testosterone replacement therapy in adult males who have deficient testosterone due to certain medical conditions Upon issuance, this patent will be...
April 28, 2022 07:30 ET | Source: InMed Pharmaceuticals Inc.

InMed Expands Patent Portfolio with Novel Cannabinoid Analogs and Advances Collaboration Agreement with Leading Cannabinoid Research Expert

Expands library of proprietary cannabinoid analogs for pharma R&DResearch collaboration initiated to screen analogs for therapeutic uses VANCOUVER, British Columbia and SOUTH SAN FRANCISCO,...
April 27, 2022 09:00 ET | Source: Avalon GloboCare Corp.

Avalon GloboCare Expands IP Portfolio; Files 16 New Patent Applications

Co-inventors are leading international universities and cellular therapy developers Patent applications cover three types of cellular therapies and related technologies FREEHOLD, N.J., April ...
April 26, 2022 09:00 ET | Source: GeoVax, Inc.

GeoVax Announces Issuance of Malaria Vaccine Patent

GeoVax’s Unique Multi-Antigenic Vaccine Approach Designed to Provide Stronger, Broader Protection Against Malaria Atlanta, GA, April 26, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs,...
April 26, 2022 08:30 ET | Source: Evoke Pharma, Inc.

Evoke Pharma Granted FDA Market Exclusivity for GIMOTI®

SOLANA BEACH, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases,...
April 26, 2022 08:00 ET | Source: OncoC4, Inc.

OncoC4 Announces Fast Track Designation Granted by the U.S. FDA for ONC-392 Monotherapy in PD(L)1-Resistant NSCLC

ROCKVILLE, Md., April 26, 2022 (GLOBE NEWSWIRE) -- OncoC4, Inc., a clinical stage biopharma company developing novel immunotherapies for cancer, announced today that the U.S. Food and Drug...
April 26, 2022 07:39 ET | Source: University of the Free state

Theranostics in the fight against cancer

Bloemfontein, April 26, 2022 (GLOBE NEWSWIRE) -- According to the World Health Organisation (WHO), cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or...
April 25, 2022 07:00 ET | Source: Tilray Brands, Inc.

Breckenridge Distillery to Release New Collectors Art Series with Denver Artist Alexandrea Pangburn

BRECKENRIDGE, Colo., April 25, 2022 (GLOBE NEWSWIRE) -- For the second year, Breckenridge Distillery – the world’s highest distillery and most awarded craft distillery in the US – combines the art...
April 20, 2022 08:50 ET | Source: Agriforce Growing Systems Ltd.

AgriFORCE Growing Systems Receives Notice of Allowance from Canadian Intellectual Property Office for AgriFORCE GrowHouse Facility Related Patent

VANCOUVER, British Columbia, April 20, 2022 (GLOBE NEWSWIRE) -- AgriFORCE Growing Systems Ltd. (“the Company") (NASDAQ: AGRI; AGRIW), an intellectual property (IP)-focused AgTech company dedicated...